Davis Polk Leads Roche In $2.4B Foundation Medicine Buy
Roche, advised by Davis Polk & Wardwell LLP, on Tuesday unveiled plans to take over Massachusetts-based molecular information company Foundation Medicine in a $2.4 billion deal, as the Swiss drugmaker looks...To view the full article, register now.
Already a subscriber? Click here to view full article